Bromophenol blue staining of tumors in a rat glioma model

Neurosurgery

Volumn 57, Issue 5, 2005, Pages 1041-1046

  Ozawa, Tomoko ^a   Britz, Gavin W ^b   Kinder, David H ^c   Spence, Alexander M ^b   VandenBerg, Scott ^a   Lamboorn, Kathleen R ^a   Deen, Dennis F ^a   Berger, Mitchel S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c OHIO NORTHERN UNIVERSITY   (United States)

Author keywords

9L rat brain tumor; Brain tumor; Bromophenol blue staining

Indexed keywords

BROMOPHENOL BLUE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; GLIOMA; MALE; NEUROSURGERY; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; RAT; TOXICITY; TUMOR LOCALIZATION; TUMOR VOLUME;

ANIMALS; BRAIN NEOPLASMS; BROMPHENOL BLUE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIOMA; INDICATORS AND REAGENTS; MALE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; RATS; RATS, INBRED F344; TIME FACTORS;

EID: 27644450614     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000180036.42193.f6     Document Type: Article

References (26)

1. Ames BN, McCann J, Yamasaki E: Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat Res 31:347-364, 1975.
2. Brown JP, Roehm GW, Brown RJ: Mutagenicity testing of certified food colors and related azo, xanthene and triphenylmethane dyes with the Salmonella/microsome system. Mutat Res 56:249-271, 1978.
3. Buckner JC: Factors influencing survival in high-grade gliomas. Semin Oncol 30:10-14, 2003.
4. Cheng MK, McKean J, Boisvert D, Tulip J: Photoradiation therapy: Current status and applications in the treatment of brain tumors. Surg Neurol 25:423-435, 1986.
5. Choucair AK, Levin VA, Gutin PH, Davis RL, Silver P, Edwards MS, Wilson CB: Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomas. J Neurosurg 65:654-658, 1986.
6. Golfinos JG, Fitzpatrick BC, Smith LR, Spetzler RF: Clinical use of a frameless stereotactic arm: Results of 325 cases. J Neurosurg 83:197-205, 1995.
7. Gooding GA, Boggan JE, Weinstein PR: Characterization of intracranial neoplasms by CT and intraoperative sonography. Am J Neuroradiol 5:517-520, 1984.
8. Graffi A: Selective, time dependent accumulation of the triphenylmethane dyes bromphenol blue, bromoresol green and iodophenol blue in mouse tumors [in German]. Z Exp Chir 14:325-335, 1981.
9. Greene GM, Hitchon PW, Schelper RL, Yuh W, Dyste GN: Diagnostic yield in CT-guided stereotactic biopsy of gliomas. J Neurosurg 71:494-497, 1989.
10. Grief P: 5-Aminolevulinic acid (ALA) and its applications in neurosurgery. Neurol Neurochir Pol 38:201-207, 2004.
11. Jeremic B, Milicic B, Grujicic D, Dagovic A, Aleksandrovic J, Nikolic N: Clinical prognostic factors in patients with malignant glioma treated with combined modality approach. Am J Clin Oncol 27:195-204, 2004.
12. Kelly PJ, Daumas-Duport C, Kispert DB, Kall BA, Scheithauer BW, Illig JJ: Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 66:865-874, 1987.
13. Laws ER Jr, Parney IF, Huang W, Anderson F, Morris AM, Asher A, Lillehei KO, Bernstein M, Brem H, Sloan A, Berger MS, Chang S: Glioma Outcomes Investigators: Survival following surgery and prognostic factors for recently diagnosed malignant glioma: Data from the Glioma Outcomes Project. J Neurosurg 99:467-473, 2003.
14. LeRoux PD, Berger MS, Ojemann GA, Wang K, Mack LA: Correlation of intraoperative ultrasound tumor volumes and margins with preoperative computerized tomography scans. An intraoperative method to enhance tumor resection. J Neurosurg 71:691-698, 1989.
15. Lin GH, Brusick DJ: Mutagenicity studies on two triphenylmethane dyes, bromophenol blue and tetrabromophenol blue. J Appl Toxicol 12:267-274, 1992.
16. Mornex F, Nayel H, Taillandier L: Radiation therapy for malignant astrocytomas in adults. Radiother Oncol 27:181-192, 1993.
17. Ohki M, Sakurada K, Sonoda Y, Sato S, Saito S, Kayama T: Analysis of the extent of astrocytic tumour resection evaluated by magnetic resonance images. Neurosurg Rev 26:262-265, 2003.
18. Ozawa T, Wang J, Hu LJ, Bollen AW, Lamborn KR, Deen DF: Growth of human glioblastomas as xenografts in the brains of athymic rats. In Vivo 16:55-60, 2002.
19. Patwardhan RV, Shorter C, Willis BK, Reddy P, Smith D, Caldito GC, Nanda A: Survival trends in elderly patients with glioblastoma multiforme: Resective surgery, radiation, and chemotherapy. Surg Neurol 62:207-213; discussion 214-255, 2004.
20. Pavlicevic G, Roganovic Z: Outcome of surgical treatment of malignant astrocytoma of the brain [in Serbian]. Vojnosanit Fregl 60:147-154, 2003.
21. Perria C, Carai M, Falzoi A, Orunesu G, Rocca A, Massarelli G, Francaviglia N, Jori G: Photodynamic therapy of malignant brain tumors: Clinical results of, difficulties with, questions about, and future prospects for the neurosurgical applications. Neurosurgery 23:557-563, 1988.
22. Saito R, Bringas J, Mirek H, Berger MS, Bankiewicz KS: Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: A tumor model mimicking a recurrent malignant glioma. J Neurosurg 101:826-831, 2004.
23. Senekowitsch R, Mollenstadt S: Prolonged retention of 77Br labelled bromphenol blue in tumor tissue. Int J Nucl Med Biol 11:60-63, 1984.
24. Stadibauer A, Moser E, Gruber S, Nimsky C, Fahlbusch R, Ganslandt O: Integration of biochemical images of a tumor into frameless stereotaxy achieved using a magnetic resonance imaging/magnetic resonance spectroscopy hybrid data set. J Neurosurg 101:287-294, 2004.
25. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ: Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: A prospective study in 52 consecutive patients. J Neurosurg 93:1003-1013, 2000.
26. Winger MJ, Macdonald DR, Cairncross JG: Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg 71:487-493, 1989.